Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 4, 2015, Pages 727-736

  Jensen, M B F ^a,d   Olsen, K E P ^b   Nielsen, X C ^a   Hoegh, A M ^c   Dessau, R B ^a   Atlung, T ^d   Engberg, J ^a  

^a SLAGELSE HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d ROSKILDE UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN ADP RIBOSYLATING TOXIN CLOSTRIDIUM DIFFICILE TRANSFERASE A; ACTIN ADP RIBOSYLATING TOXIN CLOSTRIDIUM DIFFICILE TRANSFERASE B; BOVINE SERUM ALBUMIN; CLOSTRIDIUM TOXIN; CLOSTRIDIUM TOXIN A; CLOSTRIDIUM TOXIN B; CLOSTRIDIUM TOXIN C; UNCLASSIFIED DRUG; BACTERIAL TOXIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EXPANDED TOXIGENIC CULTURE; FECES ANALYSIS; FEMALE; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID AMPLIFICATION KIT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RIBOTYPING; SENSITIVITY AND SPECIFICITY; TOXIGENIC CULTURE; TOXIN ANALYSIS; TOXINOTYPING; CLOSTRIDIUM INFECTIONS; COMPARATIVE STUDY; CULTURE TECHNIQUE; DENMARK; EVALUATION STUDY; FECES; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PEPTOCLOSTRIDIUM DIFFICILE; PRESCHOOL CHILD; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TOXINS; CELL CULTURE TECHNIQUES; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DENMARK; FECES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84925539915     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2284-7     Document Type: Article

References (48)

1. Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML et al (2008) Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 13(31). pii: 18942
2. Janezic S, Ocepek M, Zidaric V, Rupnik M (2012) Clostridium difficile genotypes other than ribotype 078 that are prevalent among human, animal and environmental isolates. BMC Microbiol 12:48
3. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP et al (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353(23):2433–2441
4. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, Shine B et al (2013) Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis 56(11):1589–1600
5. Pépin J, Valiquette L, Cossette B (2005) Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173(9):1037–1042
6. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW et al (2008) Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47(9):1162–1170
7. Voth DE, Ballard JD (2005) Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18(2):247–263
8. Curry SR, Marsh JW, Muto CA, O’Leary MM, Pasculle AW, Harrison LH (2007) tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 45(1):215–221
9. Murray R, Boyd D, Levett PN, Mulvey MR, Alfa MJ (2009) Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infect Dis 9:103
10. Goldenberg SD, French GL (2011) Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect 62(5):355–362
11. Verdoorn BP, Orenstein R, Rosenblatt JE, Sloan LM, Schleck CD, Harmsen WS et al (2010) High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis 66(1):24–28
12. Stewart DB, Berg AS, Hegarty JP (2014) Single nucleotide polymorphisms of the tcdC gene and presence of the binary toxin gene predict recurrent episodes of Clostridium difficile infection. Ann Surg 260(2):299–304
13. Bouvet PJ, Popoff MR (2008) Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR. J Clin Microbiol 46(11):3703–3713
14. Stewart DB, Berg A, Hegarty J (2013) Predicting recurrence of C. difficile colitis using bacterial virulence factors: binary toxin is the key. J Gastrointest Surg 17(1):118–124
15. Bacci S, Mølbak K, Kjeldsen MK, Olsen KE (2011) Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis 17(6):976–982
16. Wilson IG (1997) Inhibition and facilitation of nucleic acid amplification. Appl Environ Microbiol 63(10):3741–3751
17. Kreader CA (1996) Relief of amplification inhibition in PCR with bovine serum albumin or T4 gene 32 protein. Appl Environ Microbiol 62(3):1102–1106
18. Persson S, Torpdahl M, Olsen KE (2008) New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect 14(11):1057–1064
19. Persson S, Jensen JN, Olsen KE (2011) Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC. J Clin Microbiol 49(12):4299–4300
20. O’Neill GL, Ogunsola FT, Brazier JS, Duerden BI (1996) Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 2(4):205–209
21. Stubbs SL, Brazier JS, O’Neill GL, Duerden BI (1999) PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37(2):461–463
22. Rupnik M, Avesani V, Janc M, von Eichel-Streiber C, Delmée M (1998) A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36(8):2240–2247
23. Hoegh AM, Nielsen JB, Lester A, Friis-Møller A, Schønning K (2011) A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1. Eur J Clin Microbiol Infect Dis 31(6):1073–1079
24. de Boer RF, Wijma JJ, Schuurman T, Moedt J, Dijk-Alberts BG, Ott A et al (2010) Evaluation of a rapid molecular screening approach for the detection of toxigenic Clostridium difficile in general and subsequent identification of the tcdC Delta117 mutation in human stools. J Microbiol Methods 83(1):59–65
25. Niesters HG (2001) Quantitation of viral load using real-time amplification techniques. Methods 25(4):419–429
26. Pepe MS (2003) Comparing binary tests and regression analysis. In: The statistical evaluation of medical tests for classification and prediction. Oxford University Press, New York, pp 35–65
27. Wilcox MH, Planche T, Fang FC, Gilligan P (2010) What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J Clin Microbiol 48(12):4347–4353
28. Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA et al (2013) Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 13(11):936–945
29. Berry N, Sewell B, Jafri S, Puli C, Vagia S, Lewis AM et al (2014) Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection. J Hosp Infect 87(2):109–114
30. Hink T, Burnham CA, Dubberke ER (2013) A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens. Anaerobe 19:39–43
31. Hill KA, Collins J, Wilson L, Perry JD, Gould FK (2013) Comparison of two selective media for the recovery of Clostridium difficile from environmental surfaces. J Hosp Infect 83(2):164–166
32. Perry JD, Asir K, Halimi D, Orenga S, Dale J, Payne M et al (2010) Evaluation of a chromogenic culture medium for isolation of Clostridium difficile within 24 hours. J Clin Microbiol 48(11):3852–3858
33. Peterson LR, Mehta MS, Patel PA, Hacek DM, Harazin M, Nagwekar PP et al (2011) Laboratory testing for Clostridium difficile infection: light at the end of the tunnel. Am J Clin Pathol 136(3):372–380
34. van den Berg RJ, Ameen HA, Furusawa T, Claas EC, van der Vorm ER, Kuijper EJ (2005) Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies. J Med Microbiol 54(Pt 2):173–179
35. Hell M, Permoser M, Chmelizek G, Kern JM, Maass M, Huhulescu S et al (2011) Clostridium difficile infection: monoclonal or polyclonal genesis? Infection 39(5):461–465
36. Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P et al (2010) Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 48(10):3719–3724
37. René P, Frenette CP, Schiller I, Dendukuri N, Brassard P, Fenn S et al (2012) Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type. Diagn Microbiol Infect Dis 73(1):94–96
38. Goldenberg SD, Gumban M, Hall A, Patel A, French GL (2011) Lack of effect of strain type on detection of toxigenic Clostridium difficile by glutamate dehydrogenase and polymerase chain reaction. Diagn Microbiol Infect Dis 70(3):417–419
39. Babady NE, Stiles J, Ruggiero P, Khosa P, Huang D, Shuptar S et al (2010) Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol 48(12):4519–4524
40. Pancholi P, Kelly C, Raczkowski M, Balada-Llasat JM (2012) Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays. J Clin Microbiol 50(4):1331–1335
41. Kuijper EJ, Coignard B, Tüll P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control (2006) Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12(Suppl 6):2–18
42. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M et al (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377(9759):63–73
43. Persson S, de Boer RF, Kooistra-Smid AM, Olsen KE (2011) Five commercial DNA extraction systems tested and compared on a stool sample collection. Diagn Microbiol Infect Dis 69(3):240–244
44. Monteiro L, Bonnemaison D, Vekris A, Petry KG, Bonnet J, Vidal R et al (1997) Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J Clin Microbiol 35(4):995–998
45. Akane A, Matsubara K, Nakamura H, Takahashi S, Kimura K (1994) Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains, a major inhibitor of polymerase chain reaction (PCR) amplification. J Forensic Sci 39(2):362–372
46. Abu Al-Soud W, Rådström P (2000) Effects of amplification facilitators on diagnostic PCR in the presence of blood, feces, and meat. J Clin Microbiol 38(12):4463–4470
47. Kaneko H, Kawana T, Fukushima E, Suzutani T (2007) Tolerance of loop-mediated isothermal amplification to a culture medium and biological substances. J Biochem Biophys Methods 70(3):499–501
48. Nixon G, Garson JA, Grant P, Nastouli E, Foy CA, Huggett JF (2014) Comparative study of sensitivity, linearity, and resistance to inhibition of digital and nondigital polymerase chain reaction and loop mediated isothermal amplification assays for quantification of human cytomegalovirus. Anal Chem 86(9):4387–4394